Akums Drugs has entered into a strategic partnership with a prominent global pharmaceutical company to supply specific oral liquid formulations to the European market. The...
About Akums Drugs & Pharmaceuticals IPO The Akums Drugs and Pharmaceuticals IPO amounts to Rs 1856.74 crores which is a book-built issue. The Offer consists...
Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients. Orally administered by statin-intolerant patients,...